IKONISYS SA (ALIKO.PA) Stock Price, Forecast & Analysis
Europe - Euronext Paris - EPA:ALIKO - FR00140048X2 - Common Stock
ALIKO.PA Key Statistics, Chart & Performance
The current stock price of ALIKO.PA is 1.41 EUR. In the past month the price decreased by -4.08%. In the past year, price decreased by -4.73%.
ALIKO.PA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 18.39 | 114.62B | ||
| 1MDT.MI | MEDTRONIC PLC | 18.64 | 114.29B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 17.88 | 48.21B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 16.39 | 23.36B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 16.37 | 23.33B | ||
| 1PHIA.MI | KONINKLIJKE PHILIPS NV | 16.67 | 23.11B | ||
| BIM.PA | BIOMERIEUX | 28.32 | 12.94B | ||
| OBCK.DE | OTTOBOCK SE & CO KGAA | 155.11 | 4.66B | ||
| AFX.DE | CARL ZEISS MEDITEC AG - BR | 26.15 | 4.00B | ||
| DIA.MI | DIASORIN SPA | 18.56 | 3.44B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 10.93 | 1.32B | ||
| DRW8.DE | DRAEGERWERK AG | 9.86 | 1.19B |
Related stock screener links
About ALIKO.PA
Company Profile
Ikonisys SA specializes in the design, manufacture, and distribution of cellular diagnosis applications for cancer, genetic diseases, and fertility problems. The company is headquartered in Paris, Ile-De-France and currently employs 10 full-time employees. The company went IPO on 2021-07-19. The firm offers cell diagnostic products in the fields of cancer diagnosis, detection of genetic disorders, and fertility testing. The company utilizes advanced molecular and immunological markers, Ikoniscope robotic components, software engine, image acquisition, digital microscope and cell detection to design and deliver accurate and reliable detection of rare cells. The company includes clinical diagnostic applications for the diagnosis of different types of cancer, including bladder (oncoFISH bladder), breast (oncoFISH her2), cervical (oncoFISH cervical), prostate (oncoFISH PTEN), lung (oncoFISH ALK) and a variety of hematological cancers utilizing the Explorer applications.
Company Info
IKONISYS SA
62 Rue De Caumartin, Paris 9
Paris ILE-DE-FRANCE FR
Employees: 10
IKONISYS SA / ALIKO.PA FAQ
What does IKONISYS SA do?
Ikonisys SA specializes in the design, manufacture, and distribution of cellular diagnosis applications for cancer, genetic diseases, and fertility problems. The company is headquartered in Paris, Ile-De-France and currently employs 10 full-time employees. The company went IPO on 2021-07-19. The firm offers cell diagnostic products in the fields of cancer diagnosis, detection of genetic disorders, and fertility testing. The company utilizes advanced molecular and immunological markers, Ikoniscope robotic components, software engine, image acquisition, digital microscope and cell detection to design and deliver accurate and reliable detection of rare cells. The company includes clinical diagnostic applications for the diagnosis of different types of cancer, including bladder (oncoFISH bladder), breast (oncoFISH her2), cervical (oncoFISH cervical), prostate (oncoFISH PTEN), lung (oncoFISH ALK) and a variety of hematological cancers utilizing the Explorer applications.
What is the stock price of IKONISYS SA today?
The current stock price of ALIKO.PA is 1.41 EUR. The price decreased by -0.7% in the last trading session.
Does ALIKO stock pay dividends?
ALIKO.PA does not pay a dividend.
What is the ChartMill rating of IKONISYS SA stock?
ALIKO.PA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Would investing in IKONISYS SA be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ALIKO.PA.
ALIKO.PA Technical Analysis
ALIKO.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to ALIKO.PA. ALIKO.PA has a bad profitability rating. Also its financial health evaluation is rather negative.
ALIKO.PA Financial Highlights
Over the last trailing twelve months ALIKO.PA reported a non-GAAP Earnings per Share(EPS) of -0.27. The EPS decreased by -6.92% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -10.87% | ||
| ROE | -14.41% | ||
| Debt/Equity | 0.1 |
ALIKO.PA Forecast & Estimates
9 analysts have analysed ALIKO.PA and the average price target is 2.86 EUR. This implies a price increase of 102.55% is expected in the next year compared to the current price of 1.41.